Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abu-Zant, A., M. Santic, M. Molmeret, S. Jones, J. Helbig, and Y. Abu Kwaik. 2005.Incomplete activation of macrophage apoptosis during intracellular replication of Legionella pneumophila. Infect Immun 73:5339–49.
Akamine, M., F. Higa, N. Arakaki, K. Kawakami, K. Takeda, S. Akira, and A. Saito. 2005. Differential roles of Toll-like receptors 2 and 4 in in vitro responses of macrophages to Legionella pneumophila. Infect Immun 73:352–61.
Andrews, H. L., J. P. Vogel, and R. R. Isberg. 1998. Identification of linked Legionella pneumophilagenes essential for intracellular growth and evasion of the endocytic pathway. Infect Immun 66:950–8.
Arata, S., C. Newton, T. W. Klein, Y. Yamamoto, and H. Friedman. 1993. Legionella pneumophilainduced tumor necrosis factor production in permissive versus nonpermissive macrophages. Proc Soc Exp Biol Med 203:26–9.
Archer, K. A., and C. R. Roy. 2006. MyD88-dependent responses involving toll-like receptor 2 are important for protection and clearance of Legionella pneumophilain a mouse model of Legionnaires’ disease. Infect Immun 74:3325–33.
Blanchard, D. K., J. Y. Djeu, T. W. Klein, H. Friedman, and W. E. Stewart. 1987. Induction of tumor necrosis factor by Legionella pneumophila. Infect Immun 55:433–7.
Braedel-Ruoff, S., M. Faigle, N. Hilf, B. Neumeister, and H. Schild. 2005. Legionella pneumophilamediated activation of dendritic cells involves CD14 and TLR2. J Endotoxin Res 11:89–96.
Byrd, T. F., and M. A. Horwitz. 1991. Chloroquine inhibits the intracellular multiplication of Legionella pneumophilaby limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J Clin Invest 88:351–7.
Derre, I., and R. R. Isberg. 2004. Macrophages from mice with the restrictive Lgn1 allele exhibit multifactorial resistance to Legionella pneumophila. Infect Immun 72:6221–9.
Dietrich, C., K. Heuner, B. C. Brand, J. Hacker, and M. Steinert. 2001. Flagellum of Legionella pneumophilapositively affects the early phase of infection of eukaryotic host cells. Infect Immun 69:2116–22.
Diez, E., S. H. Lee, S. Gauthier, Z. Yaraghi, M. Tremblay, S. Vidal, and P. Gros. 2003. Birc1e is the gene within the Lgn1 locus associated with resistance to Legionella pneumophila. Nat Genet 33:55–60.
Edson, D. C., H. E. Stiefel, B. B. Wentworth, and D. L. Wilson. 1979. Prevalence of antibodies to Legionnaires’ disease. A seroepidemiologic survey of Michigan residents using the hemagglutination test. Ann Intern Med 90:691–3.
Egawa, K., T. W. Klein, Y. Yamamoto, C. A. Newton, and H. Friedman. 1992. Enhanced growth restriction of Legionella pneumophilain endotoxin- treated macrophages. Proc Soc Exp Biol Med 200:338–42.
Fields, B. S. 1996. The molecular ecology of legionellae. Trends Microbiol 4:286–90.
Finegold, S. M. 1988. Legionnaires’ disease—still with us [editorial]. N Engl J Med 318:571–3.
Fischer, S. F., J. Vier, C. Muller-Thomas, and G. Hacker. 2006. Induction of apoptosis by Legionella pneumophilain mammalian cells requires the mitochondrial pathway for caspase activation. Microbes Infect 8:662–9.
Fortier, A., E. Diez, and P. Gros. 2005. Naip5/Birc1e and susceptibility to Legionella pneumophila. Trends Microbiol 13:328–35.
Fraser, D. W., T. R. Tsai, W. Orenstein, W. E. Parkin, H. J. Beecham, R. G. Sharrar, J. Harris, G. F. Mallison, S. M. Martin, J. E. McDade, C. C. Shepard, and P. S. Brachman. 1977. Legionnaires’ disease: description of an epidemic of pneumonia. N Engl J Med 297:1189–97.
Freedman, A. P., and S. M. Katz. 1981. The prevalence of serum antibodies to Legionella pneumophilain patients with chronic pulmonary disease. Am Rev Respir Dis 123:238–9.
Friedman, H., Y. Yamamoto, and T. W. Klein. 2002. Legionella pneumophilapathogenesis and immunity. Semin Pediatr Infect Dis 13:273–9.
Friedman, H., Y. Yamamoto, C. Newton, and T. Klein. 1998. Immunologic response and pathophysiology of Legionella infection. Semin Respir Infect 13:100–8.
Gebran, S. J., Y. Yamamoto, C. Newton, T. W. Klein, and H. Friedman. 1994. Inhibition of Legionella pneumophilagrowth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III). Infect Immun 62:3197–205.
Girard, R., T. Pedron, S. Uematsu, V. Balloy, M. Chignard, S. Akira, and R. Chaby. 2003. Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2. J Cell Sci 116:293–302.
Hawn, T. R., K. D. Smith, A. Aderem, and S. J. Skerrett. 2006. Myeloid Differentiation Primary Response Gene (88)- and Toll-Like Receptor 2-Deficient Mice Are Susceptible to Infection with Aerosolized Legionella pneumophila. J Infect Dis 193:1693–702.
Hawn, T. R., A. Verbon, K. D. Lettinga, L. P. Zhao, S. S. Li, R. J. Laws, S. J. Skerrett, B. Beutler, L. Schroeder, A. Nachman, A. Ozinsky, K. D. Smith, and A. Aderem. 2003. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to legionnaires’ disease. J Exp Med 198:1563–72.
Heath, L., C. Chrisp, G. Huffnagle, M. LeGendre, Y. Osawa, M. Hurley, C. Engleberg, J. Fantone, and J. Brieland. 1996. Effector mechanisms responsible for gamma interferon-mediated host resistance to Legionella pneumophilalung infection: the role of endogenous nitric oxide differs in susceptible and resistant murine hosts. Infect Immun 64:5151–60.
Hoffman, P. S., L. Houston, and C. A. Butler. 1990. Legionella pneumophilahtpAB heat shock operon: nucleotide sequence and expression of the 60-kilodalton antigen in L. pneumophila-infected HeLa cells. Infect Immun 58:3380–7.
Horwitz, M. A., and S. C. Silverstein. 1980. Legionnaires’ disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes. J Clin Invest 66:441–50.
Huang, L. Y., K. J. Ishii, S. Akira, J. Aliberti, and B. Golding. 2005. Th1-like cytokine induction by heat-killed Brucella abortus is dependent on triggering of TLR9. J Immunol 175:3964–70.
Kikuchi, T., T. Kobayashi, K. Gomi, T. Suzuki, Y. Tokue, A. Watanabe, and T. Nukiwa. 2004. Dendritic cells pulsed with live and dead Legionella pneumophilaelicit distinct immune responses. J Immunol 172:1727–34.
Klein, T. W., H. Friedman, and S. Specter. 1998. Marijuana, immunity and infection. J Neuroimmunol 83:102–15.
Klein, T. W., Y. Kawakami, C. Newton, and H. Friedman. 1991. Marijuana components suppress induction and cytolytic function of murine cytotoxic T cells in vitro and in vivo. J Toxicol Environ Health 32:465–77.
Klein, T. W., C. Newton, R. Widen, and H. Friedman. 1993. Delta 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila. J Pharmacol Exp Ther 267:635–40.
Klein, T. W., C. A. Newton, N. Nakachi, and H. Friedman. 2000. Delta 9-tetrahydrocannabinol treatment suppresses immunity and early IFN-gamma, IL-12, and IL-12 receptor beta 2 responses to Legionella pneumophilainfection. J Immunol 164:6461–6.
Lu, T., C. Newton, I. Perkins, H. Friedman, and T. W. Klein. 2006. Cannabinoid treatment suppresses the T helper cell polarizing function of mouse dendritic cells stimulated with Legionella pneumophilainfection. J Pharmacol Exp Ther 319:269–276.
Lu, T., C. Newton, I. Perkins, H. Friedman, and T. W. Klein. 2006. Role of cannabinoid receptors in Delta-9-tetrahydrocannabinol suppression of IL-12p40 in mouse bone marrow-derived dendritic cells infected with Legionella pneumophila. Eur J Pharmacol 532:170–7.
Matsunaga, K., T. W. Klein, C. Newton, H. Friedman, and Y. Yamamoto. 2001. Legionella pneumophilasuppresses interleukin-12 production by macrophages. Infect Immun 69:1929–33.
Matsunaga, K., H. Yamaguchi, T. W. Klein, H. Friedman, and Y. Yamamoto. 2003. Legionella pneumophilasuppresses macrophage interleukin-12 production by activating the p42/44 mitogen-activated protein kinase cascade. Infect Immun 71:6672–5.
McDade, J. E., C. C. Shepard, D. W. Fraser, T. R. Tsai, M. A. Redus, and W. R. Dowdle. 1977. Legionnaires’ disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N Engl J Med 297:1197–203.
McHugh, S. L., C. A. Newton, Y. Yamamoto, T. W. Klein, and H. Friedman. 2000. Tumor necrosis factor induces resistance of macrophages to Legionella pneumophilainfection. Proc Soc Exp Biol Med 224:191–6.
McHugh, S. L., Y. Yamamoto, T. W. Klein, and H. Friedman. 2000. Murine macrophages differentially produce proinflammatory cytokines after infection with virulent vs. avirulent Legionella pneumophila. J Leukoc Biol 67:863–8.
Molofsky, A. B., B. G. Byrne, N. N. Whitfield, C. A. Madigan, E. T. Fuse, K. Tateda, and M. S. Swanson. 2006. Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophilainfection. J Exp Med 203:1093–104.
Nakachi, N., K. Matsunaga, T. W. Klein, H. Friedman, and Y. Yamamoto. 2000. Differential effects of virulent versus avirulent Legionella pneumophilaon chemokine gene expression in murine alveolar macrophages determined by cDNA expression array technique. Infect Immun 68:6069–72.
Newton, C., S. McHugh, R. Widen, N. Nakachi, T. Klein, and H. Friedman. 2000. Induction of interleukin-4 (IL-4) by Legionella pneumophilainfection in BALB/c mice and regulation of tumor necrosis factor alpha, IL-6, and IL-1beta. Infect Immun 68:5234–40.
Newton, C. A., T. W. Klein, and H. Friedman. 1994. Secondary immunity to Legionella pneumophilaand Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect Immun 62:4015–20.
Newton, C. A., I. Perkins, R. H. Widen, H. Friedman, and T. W. Klein. 2006. Role of TLR9 in Legionella pneumophila-induced IL-12p40 production in bone marrow-derived dendritic cells and macrophages from permissive and non-permissive mice. Infect Immun.
Newton, C. A., R. Widen, H. Friedman, and T. W. Klein. 1994. Lymphocyte subset changes following primary and secondary infection of mice with Legionella pneumophila. Immunology & Infectious Diseases 5:18–26.
Plouffe, J. F., and I. M. Baird. 1982. Lymphocyte blastogenic responses to L. pneumophilain acute Legionellosis. J Clin Lab Immunol 7:43–4.
Ren, T., D. S. Zamboni, C. R. Roy, W. F. Dietrich, and R. E. Vance. 2006. Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity. PLoS Pathog 2:e18.
Salins, S., C. Newton, R. Widen, T. W. Klein, and H. Friedman. 2001. Differential Induction of Gamma Interferon in Legionella pneumophila- Infected Macrophages from BALB/c and A/J Mice. Infect Immun 69:3605–10.
Sampson, J. S., B. B. Plikaytis, and H. W. Wilkinson. 1986. Immunologic response of patients with legionellosis against major protein-containing antigens of Legionella pneumophilaserogroup 1 as shown by immunoblot analysis. J Clin Microbiol 23:92–9.
Sonesson, A., E. Jantzen, K. Bryn, L. Larsson, and J. Eng. 1989. Chemical composition of a lipopolysaccharide from Legionella pneumophila. Arch Microbiol 153:72–8.
Tateda, K., T. Matsumoto, Y. Ishii, N. Furuya, A. Ohno, S. Miyazaki, and K. Yamaguchi. 1998. Serum cytokines in patients with Legionella pneumonia: relative predominance of Th1-type cytokines. Clin Diagn Lab Immunol 5:401–3.
Weeratna, R., D. A. Stamler, P. H. Edelstein, M. Ripley, T. Marrie, D. Hoskin, and P. S. Hoffman. 1994. Human and guinea pig immune responses to Legionella pneumophilaprotein antigens OmpS and Hsp60. Infect Immun 62:3454–62.
Widen, R. H., T. W. Klein, C. A. Newton, and H. Friedman. 1989. Induction of interleukin 1 by Legionella pneumophilain murine peritoneal macrophage cultures. Proc Soc Exp Biol Med 191:304–8.
Widen, R. H., C. A. Newton, T. W. Klein, and H. Friedman. 1993. Antibody-mediated enhancement of Legionella pneumophila-induced interleukin 1 activity. Infect Immun 61:4027–32.
Winn, W. C., Jr., and R. L. Myerowitz. 1981. The pathology of the Legionella pneumonias. A review of 74 cases and the literature. Hum Pathol 12:401–22.
Yamamoto, Y., T. W. Klein, C. Newton, and H. Friedman. 1992. Differing macrophage and lymphocyte roles in resistance to Legionella pneumophilainfection. J Immunol 148:584–9.
Yamamoto, Y., T. W. Klein, C. A. Newton, and H. Friedman. 1988. Interaction of Legionella pneumophilawith peritoneal macrophages from various mouse strains. Adv Exp Med Biol 239:89–98.
Yamamoto, Y., T. W. Klein, C. A. Newton, R. Widen, and H. Friedman. 1987. Differential growth of Legionella pneumophilain guinea pig versus mouse macrophage cultures. Infect Immun 55:1369–74.
Yamamoto, Y., T. W. Klein, C. A. Newton, R. Widen, and H. Friedman. 1988. Growth of Legionella pneumophilain thioglycolate-elicited peritoneal macrophages from A/J mice. Infect Immun 56:370–5.
Yoshida, S., and Y. Mizuguchi. 1986. Multiplication of Legionella pneumophilaPhiladelphia-1 in cultured peritoneal macrophages and its correlation to susceptibility of animals. Can J Microbiol 32:438–42.
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Hoffman, P., Friedman, H., Bendinelli, M. (2008). Legionella pneumophila:Innate and Adaptive Immunity. In: Legionella pneumophila. Infectious Diseases And Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-70896-6_9
Download citation
DOI: https://doi.org/10.1007/978-0-387-70896-6_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-70895-9
Online ISBN: 978-0-387-70896-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)